

( (S (SBAR-TMP (WHADVP-1 When)
	       (S (NP-SBJ the economy)
		  (VP stumbled
		      (PP-TMP in
			      (NP the mid-1970s))
		      (ADVP-TMP *T*-1))))
     ,
     (NP-SBJ Akzo NV)
     (VP fell
         (PP-CLR out
		 (PP of
		     (NP bed))))
     .))
( (S (NP-SBJ (NP Towering overcapacity)
	     (PP-LOC in
		     (NP (NP the synthetic fiber business)
			 ,
			 (SBAR (WHNP-1 which)
			       (S (NP-SBJ *T*-1)
				  (VP accounted
				      (PP-CLR for
					      (NP (NP half)
						  (PP of
						      (NP (NP the Dutch chemical company 's)
							  sales)))))))))
	     ,)
     (VP (VP led
             (PP-CLR to
		     (NP huge losses)))
         and
         (VP left
             (NP (NP Akzo 's)
                 survival)
	     (PP-CLR in
		     (NP doubt))))
     .))
( (S-CLF (NP-SBJ It)
	 (VP was 
	     n't
	     (PP-PRD until
		     (NP the early 1980s))
	     (SBAR (WHADVP-1 that)
		   (S (NP-SBJ Akzo)
		      (VP nursed
			  (NP itself)
			  (ADVP-CLR back
				    (PP to
					(NP health)))
			  (ADVP-TMP *T*-1)))))
	 .))
( (S (ADVP-TMP Now)
     ,
     (SBAR-TMP as
	       (S (NP-SBJ (NP a new downturn)
			  (PP-LOC in
				  (NP the chemical industry)))
		  (VP looms)))
     ,
     (NP-SBJ Akzo)
     (VP says
         (SBAR 0
               (S (NP-SBJ it)
                  (VP is
                      (PP-PRD in
			      (NP (NP (ADJP far better)
				      shape) 
				  (SBAR (WHADVP-1 0)
					(S (NP-SBJ *)
					   (VP to
					       (VP cope
						   (ADVP-MNR *T*-1)))))))))))
     .))
( (S (NP-SBJ Investment analysts)
     (ADVP generally)
     (VP agree)
     .))
( (S (ADVP Aside
           (PP from
               (S-NOM (NP-SBJ *-1)
		      (VP (VP slashing
			      (NP costs))
			  and
			  (VP investing
			      (ADVP-MNR heavily)
			      (PP-CLR in
				      (NP its plants)))))))
     ,
     (NP-SBJ-1 Akzo)
     (VP has
	 (VP spent
	     (NP (NP (QP 3.9 billion) 
		     guilders)
		 (PRN -LRB-
		      (NP (QP $ 1.88 billion)
			  *U*)
		      -RRB-))
	     (PP-CLR on
		     (NP acquisitions))
	     (PP-TMP since
		     (NP 1983))
	     (S-PRP (NP-SBJ *-1)
		    (VP to
			(VP give
			    (NP it)
			    (NP better balance))))))
     .))
( (S (PP-TMP During
	     (NP the same period))
     ,
     (NP-SBJ the company)
     (VP has
         (VP sold
             (NP (NP (QP about 1.6 billion)
		     guilders)
                 (PP of
                     (NP assets)))))
     .))
( (S (NP-SBJ (NP The fibers business)
             ,
             (SBAR (WHNP-1 whose products)
                   (S (NP-SBJ *T*-1)
                      (VP go
                          (PP-CLR into
				  (NP (NP textiles)
				      ,
				      (NP carpeting)
				      and
				      (NP myriad industrial uses))))))
             ,)
     (ADVP-TMP now)
     (VP accounts
         (PP-CLR for 
		 (NP (NP (QP only 20)
			 %)
		     (PP of
			 (NP (NP Akzo 's)
			     sales)))))
     .))
( (S ``
     (S-TPC-1 (NP-SBJ We)
	      (VP have
		  (ADVP definitely)
		  (VP become
		      (ADJP-PRD less cyclical))))
     , 
     ''
     (NP-SBJ (NP Syb Bergsma)
	     ,
	     (NP executive vice president-finance)
	     ,)
     (VP said
	 (S *T*-1)
	 (PP-LOC in
		 (NP an interview)))
     .))
( (S (INTJ Still)
     ,
     (NP-SBJ Akzo)
     (VP has 
	 n't
         (ADVP-TMP yet)
         (VP found
             (NP (NP a way)
                 (SBAR (WHADVP-1 0)
		       (S (NP-SBJ *)
			  (VP to
			      (VP achieve
				  (NP (NP another goal)
				      :
				      (NP (NP a large presence)
					  (PP-LOC in
						  (NP (NP the U.S. market)
						      (PP for
							  (NP prescription drugs))))))
				  (ADVP-MNR *T*-1))))))))
     .))
( (S (NP-SBJ Mr. Bergsma)
     (VP said
         (SBAR 0
               (S (NP-SBJ (NP prices)
                          (PP for
                              (NP U.S. pharmaceutical companies)))
                  (VP remain
		      (ADJP-PRD too
				high)
                      ,
                      (S-ADV (NP-SBJ *)
			     (VP making
				 (S (NP-SBJ (NP it)
					    (SBAR *EXP*-1))
				    (ADJP-PRD unlikely)
				    (SBAR-1 that
					    (S (NP-SBJ Akzo)
					       (VP will
						   (VP pursue
						       (NP any major acquisitions)
						       (PP-LOC in
							       (NP that area)))))))))))))
     .))
( (S But
     (NP-SBJ he)
     (VP said
         (SBAR 0
               (S (NP-SBJ Akzo)
                  (VP is
                      (VP considering
                          (NP (NP `` alliances '')
                              (PP with
                                  (NP American drug companies)))))))
         ,
         (SBAR-ADV although
		   (S (NP-SBJ he)
		      (VP would
			  n't
			  (VP elaborate)))))
     .))
( (S (NP-SBJ (NP An indication)
             (PP of
                 (NP (NP (NP Akzo 's)
			 success)
                     (PP in
                         (S-NOM (NP-SBJ *)
				(VP reshaping
				    (NP itself)))))))
     (VP will
         (VP come
             (NP-TMP Thursday)
             (SBAR-TMP (WHADVP-1 when)
		       (S (NP-SBJ it)
			  (VP reports
			      (NP third-quarter results)
			      (ADVP-TMP *T*-1))))))
     .))
( (S (NP-SBJ Analysts)
     (VP expect
	 (S (NP-SBJ the company)
	    (VP to
                (VP show
                    (NP (NP profit)
                        (PP of
                            (NP (NP (QP about 225 million) 
				    guilders)
				,
                                (ADVP up
                                      (NP 9 %)
                                      (PP from
					  (NP (QP 206.3 million)
					      guilders)
					  (ADVP-TMP (NP a year)
						    earlier))))))))))
     .))
( (S (NP-SBJ A bigger test)
     (VP will
         (VP come
	     (NP-TMP next year)
	     (SBAR-ADV if 
		       ,
		       (S (SBAR-ADV as
				    (S (NP-SBJ many analysts)
				       (VP expect)))
			  ,
			  (NP-SBJ bulk chemical prices)
			  (VP slump
			      (PP-LOC in
				      (NP Europe)))))))
     .))
( (SINV ``
	(S-TPC-1 (ADVP Maybe)
		 (NP-SBJ Akzo)
		 (VP can
		     (VP surprise
			 (NP the investment world)
			 (NP-ADV a bit))))
	, 
	''
	(VP said
	    (S *T*-1))
	(NP-SBJ (NP Jaap Visker)
		,
		(NP (NP an analyst)
		    (PP-LOC at
			    (NP Amsterdam-Rotterdam Bank NV))))
	.))
( (S (NP-SBJ He)
     (VP figures
         (SBAR 0
               (S (NP-SBJ-1 Akzo)
                  (VP is
                      (ADJP-PRD likely
				(S (NP-SBJ *-1)
				   (VP to
				       (VP be
					   (NP-PRD (NP one)
						   (PP of
						       (NP the few major chemical companies))
						   (SBAR (WHNP-2 0)
							 (S (NP-SBJ *T*-2)
							    (VP to
								(VP show
								    (NP profit growth)
								    (NP-TMP next year))))))))))))))
     .))
( (S (NP-SBJ The bank)
     (VP projects
         (SBAR 0
               (S (NP-SBJ Akzo)
                  (VP will
                      (VP show
                          (NP (NP per-share earnings)
			      (PP of
				  (NP 24 guilders)))
                          (PP-TMP in
				  (NP 1990))
                          ,
                          (ADVP up
				(PP from
				    (NP (NP (NP an estimated 22.5 guilders)
					    (PP for
						(NP this year)))
					and
					(NP (NP the 20.9 guilders)
					    (VP reported
						(NP *)
						(PP-CLR for
							(NP 1988))))))))))))
     .))
( (S (PP-LOC At
	     (NP (NP James Capel & Co.)
		 (PP-LOC in
			 (NP London))))
     ,
     (NP-SBJ analyst
	     Jackie Ashurst)
     (VP notes
         (SBAR that
               (S (NP-SBJ Akzo)
                  (VP is
                      (ADJP-PRD (ADJP less exposed
				      (PP *ICH*-1))
				(PP than
				    (NP (NP many)
					(PP of
					    (NP its rivals))))
				(PP-1 to
				      (NP the 
					  (ADJP most volatile) 
					  chemical products)))))))
     .))
( (S (PP For
         (NP example))
     ,
     (NP-SBJ Akzo)
     (VP (VP has
             (ADVP only)
             (NP minor petrochemical operations))
         ,
         (VP is
             (ADJP-PRD small)
	     (PP-LOC in
		     (NP plastics)))
         and 
	 (VP does 
	     n't
	     (VP make
		 (NP fertilizers))))
     .))
( (S (ADVP Thus)
     ,
     (SBAR-ADV while
	       (S (NP-SBJ Akzo)
		  (VP profited
		      (ADVP (ADVP less)
			    (PP than
				(NP many rivals)))
		      (PP-CLR from
			      (NP (NP the boom)
				  (PP of
				      (NP recent years))
				  (PP-LOC in
					  (NP petrochemicals and plastics)))))))
     ,
     (NP-SBJ it)
     (VP has
	 (NP (NP less)
	     (SBAR (WHNP-1 0)
		   (S (NP-SBJ *)
		      (VP to
			  (VP fear
			      (NP *T*-1)
			      (PP from
				  (NP the current slump))))))))
     .))
( (S (NP-SBJ-1 The company)
     (VP is
         (VP exposed
             (NP *-1)
             (PP-CLR to
		     (NP bulk chemicals))
	     ,
	     (ADVP however)))
     .))
( (S (S-TPC-1 (SBAR-ADV Although
			(S (NP-SBJ-2 bulk-chemical prices)
			   (VP have
			       (VP begun
				   (S (NP-SBJ *-2)
				      (VP falling))
				   (PP-LOC in
					   (NP the U.S.))))))
	      ,
	      (NP-SBJ they)
	      (VP are
		  (ADVP generally)
		  (ADJP-PRD stable)
		  (PP-LOC in
			  (NP Europe))))
     ,
     (NP-SBJ Mr. Bergsma)
     (VP said
	 (SBAR 0
	       (S *T*-1)))
     .))
( (S-1 (S (NP-SBJ A decline)
	  (VP may
	      (VP come
		  (PP-TMP in
			  (NP (NP the first half)
			      (PP of
				  (NP 1990)))))))
       (PRN ,
	    (S (NP-SBJ he)
	       (VP said
		   (SBAR 0
			 (S *T*-1))))
	    ,) 
       but
       (S (NP-SBJ the market)
	  (VP does 
	      n't
	      (VP appear
		  (PP-LOC-PRD on
			      (NP (NP the verge)
				  (PP of
				      (NP a severe downturn)))))))
       .))
( (S (S-PRP (NP-SBJ *-1)
	    (VP To
		(VP reduce
		    (NP (NP the danger)
			(PP of
			    (NP such pricing cycles))))))
     ,
     (NP-SBJ-1 Akzo)
     (VP has
	 (VP invested
	     (ADVP-MNR heavily)
	     (PP-CLR in
		     (NP (NP specialty chemicals)
			 ,
			 (SBAR (WHNP-2 which)
			       (S (NP-SBJ-3 *T*-2)
				  (VP (VP have
					  (NP (ADJP highly specific)
					      industrial uses))
				      and
				      (VP tend
					  (S (NP-SBJ *-3)
					     (VP to
						 (VP produce
						     (NP (NP (ADJP much higher) 
							     profit margins)
							 (SBAR than
							       (SINV (VP do
									 (VP *?*))
								     (NP-SBJ bulk chemicals)))))))))))))))
     .))
( (S (NP-SBJ (NP (NP Akzo 's)
		 biggest move)
             (PP-LOC in
		     (NP this area)))
     (VP was
         (NP-PRD (NP the 1987 acquisition)
		 (PP of
		     (NP (NP Stauffer Chemical Co. 's)
			 specialty chemical business))
		 (PP for
		     (NP (QP $ 625 million) 
			 *U*))))
     .))
( (S (PP-LOC In
	     (NP a
		 (ADJP less glamorous)
		 field))
     ,
     (NP-SBJ Akzo)
     (VP is
         (NP-PRD (NP (NP the world 's)
		     biggest producer)
		 (PP of
		     (NP (NP industrial salt)
			 ,
			 (VP used
			     (NP *) 
			     (PP-CLR (PP as
					 (NP (NP a raw material)
					     (PP for
						 (NP the chemical industry))))
				     (CONJP as well as)
				     (PP for
					 (NP (NP such tasks)
					     (PP as
						 (S-NOM (NP-SBJ *)
							(VP melting
							    (NP ice))))))))))))
     .))
( (S (NP-SBJ Akzo)
     (ADVP also)
     (VP makes
         (NP (NP (NP products)
                 (VP derived
                     (NP *)
                     (PP-CLR from
			     (NP salt))))
             ,
	     (PP such as
		 (NP (NP chlorine)
		     and
		     (NP caustic soda)))))
     .))
( (S (PP-LOC In
	     (NP the fibers division))
     ,
     (NP-SBJ profit)
     (VP remains
         (ADJP-PRD weak)
	 ,
	 (PP-PRP (ADVP largely)
		 because of
		 (NP persistent overcapacity)))
     .))
( (S (S But
	(NP-SBJ Akzo)
        (VP is
            (ADVP-TMP still)
            (VP slimming 
		(PRT down))))
     :
     (S (NP-SBJ It)
        (ADVP-TMP recently)
        (VP announced
            (NP plans
		(S (NP-SBJ *)
		   (VP to
		       (VP eliminate
			   (NP (NP (QP about 1,700) 
				   fiber-related jobs)
			       (PP-LOC in
				       (NP (NP the Netherlands)
					   and
					   (NP West Germany))))))))))
     .))
( (S (SBAR-ADV Although
	       (S (NP-SBJ the polyester and rayon markets)
		  (VP remain
		      (ADJP-PRD mostly bleak))))
     ,
     (NP-SBJ Akzo)
     (VP has
         (NP (NP high hopes)
             (PP for
                 (NP (NP some emerging fiber businesses)
                     ,
		     (ADJP such 
			   (NP (NP (NP carbon fibers) 
				   and 
				   (NP aramid))
			       ,
			       (NP (NP (ADJP extremely strong) 
				       fibers)
				   (VP used
				       (NP-1 *)
				       (S-CLR (NP-SBJ *-1)
					      (VP (VP to
						      (VP reinforce
							  (NP tires and metals)))
						  and
						  (VP to
						      (VP make
							  (NP (NP such products)
							      (PP as
								  (NP bullet-proof vests)))))))))))))))
     .))
( (S (NP-SBJ (NP Akzo 's)
             Twaron aramid fiber)
     (VP is
         (NP-PRD (NP a distant second)
		 (PP to
		     (NP (NP (NP Du Pont Co. 's)
			     Kevlar)
			 ,
			 (SBAR (WHNP-1 which)
			       (S (NP-SBJ *T*-1)
				  (VP dominates
				      (NP the market))))))))
     .))
( (S (NP-SBJ Mr. Bergsma)
     (VP said
         (SBAR 0
               (S (NP-SBJ-1 (NP world-wide industry sales)
			    (PP of
				(NP aramid fibers)))
                  (VP are
                      (VP expected
                          (S (NP-SBJ *-1)
                             (VP to
                                 (VP total
                                     (NP (QP about $ 500 million) 
					 *U*)
				     (NP-TMP this year)))))))))
     .))
( (S-1 (S (NP-SBJ (NP Sales growth)
		  (PP of
		      (NP (NP 10 %)
			  (NP-ADV a year))))
	  (VP seems
	      (ADJP-PRD possible)))
       (PRN ,
	    (S (NP-SBJ he)
	       (VP said
		   (SBAR 0
			 (S *T*-1))))
	    ,) 
       and
       (S (NP-SBJ Akzo)
	  (VP expects
	      (S (NP-SBJ its Twaron business)
		 (VP to
		     (VP become
			 (ADJP-PRD profitable)
			 (PP-TMP in
				 (NP 1990)))))))
       .))
( (S (NP-SBJ Akzo)
     (ADVP also)
     (VP has
         (VP spent
             (ADVP-MNR heavily)
             (PP-CLR on
		     (NP (NP acquisitions)
			 (PP-LOC in
				 (NP (NP paints)
				     ,
				     (NP auto finishes)
				     and
				     (NP industrial coatings)))))))
     .))
( (S (PP-TMP In
	     (NP August))
     ,
     (PP for
         (NP example))
     ,
     (NP-SBJ it)
     (VP completed
         (NP (NP the 
		 (ADJP (QP $ 110 million)
		       *U*) 
		 acquisition)
             (PP of
                 (NP (NP Reliance Universal Inc.)
                     ,
                     (NP (NP a U.S. maker)
                         (PP of
                             (NP (NP industrial coatings)
                                 (PP for
                                     (NP wood
                                         ,
                                         metals
                                         and
                                         plastics)))))))
             ,
             (PP from
                 (NP Tyler Corp))))
     .))
( (S (NP-SBJ Mr. Bergsma)
     (VP said
         (SBAR 0
               (S (NP-SBJ-1 Akzo)
                  (VP is
                      (ADJP-PRD likely
				(S (NP-SBJ *-1)
				   (VP to
				       (VP see
					   (NP (NP strong profit growth)
					       (PP from
						   (NP coatings)))))))
		      (SBAR-TMP as
				(S (NP-SBJ it)
				   (VP realizes
				       (NP (NP cost savings)
					   and
					   (NP (NP other benefits)
					       (PP from
						   (NP its greater scale)))))))))))
     .))
( (S (PP For
         (NP (NP (NP Akzo 's)
		 drug business)
	     ,
	     (SBAR (WHADVP-1 where)
		   (S (NP-SBJ profits)
		      (VP have
			  (VP shown
			      (NP litle change)
			      (PP-TMP for
				      (NP the past five years))
			      (ADVP-LOC *T*-1)))))))
     ,
     (NP-SBJ Mr. Bergsma)
     (VP predicted
	 (NP moderate profit growth))
     .))
( (S (NP-SBJ Akzo)
     (VP (VP is
	     (NP-PRD (NP the leading seller)
		     (PP of
			 (NP birth-control pills)))
	     (PP-LOC in
		     (NP Europe)))
	 but 
	 (VP is 
	     (ADVP-TMP still)
	     (VP seeking
		 (NP regulatory approvals
		     (S (NP-SBJ *)
			(VP to
			    (VP enter
				(NP that market)))))
		 (PP-LOC in
			 (NP (NP the U.S.)
			     and
			     (NP Japan))))))
     .))
( (S (NP-SBJ Mr. Bergsma)
     (VP said
         (SBAR 0
               (S (NP-SBJ-1 Akzo)
                  (VP hopes
                      (S (NP-SBJ *-1)
                         (VP to
                             (VP have
                                 (NP approval
                                     (S (NP-SBJ *)
                                        (VP to
                                            (VP sell
                                                (NP its Marvelon pill)
                                                (PP-LOC in
							(NP the U.S.))))))
                                 (PP-TMP in
					 (NP 1992)))))))))
     .))
( (S (NP-SBJ Akzo)
     (ADVP also)
     (VP has
         (NP (NP small operations)
	     (PP-LOC in
		     (NP (NP diagnostic tests)
			 ,
			 (NP generic drugs)
			 and
			 (NP veterinary products)))))
     .))
( (S (S-TPC-1 (NP-SBJ Veterinary products)
	      (VP are
		  (VP showing
		      (NP (ADJP especially strong)
			  growth))))
     ,
     (NP-SBJ Mr. Bergsma)
     (VP said
	 (SBAR 0
	       (S *T*-1)))
     .))
( (SINV (PP-LOC-PRD-TPC-1 Among
			  (NP the leading products))
        (VP is
	    (PP-LOC-PRD *T*-1))
        (NP-SBJ (NP a flu shot)
                (PP for
                    (NP horses)))
	.))
